Fig. 11

Association between NIRS, clinical prognostic features and treatment sensitivity in UCEC. A, B The distribution proportion of three pathological grades in patients with high- and low- NIRS and the difference of NIRS scores in patients with different pathological grades. C, D The distribution proportion of four clinical stages in patients with high- and low- NIRS and the difference of NIRS scores in patients with different clinical stages. E–H K-M survival analyses of patients with high- and low- NIRS in different pathological grades and clinical stages. (I–P) Drug susceptibility analyses of different NIRS groups, the predicted IC50 values of cisplatin (I), docetaxel (J), paclitaxel (K), epirubicin (L), topotecan (M), temsirolimus (N), olaparib (O) and tamoxifen (P) were compared between the two groups